Easywell Biomedicals, Inc.
1799
Rank in Stocks
#19894
Easywell Biomedicals, Inc., together with its subsidiaries, develops,... Easywell Biomedicals, Inc., together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients and over-the-counter drug products in America. It operates through Drug Development and Other segments. The company develops TLX-001, an anti-cough medicine; TLX-005, an anti-urinary incontinence medicine; TLX-006 for treatment of breast cancer in PMS women; TLX-007 and TLX-004, an anti-depressant; TLX-008 for prevention of pneumocystis pneumonia; TLX-012 for treatment of epilepsy; TLX-017 for treatment of chronic angina; TLX-011 for treatment of inflammatory lesions of rosacea; TLX-015 a prevention and treatment medicine for postpartum hemorrhage; TLX-018, a hemorrhage treatment drug; TLX-030, an anti-inflammatory medicine; TLX-47, an anti-inflammatory drug; and TLX-024, an anticonvulsant. It also develops TWB-201 for Parkinson patch; TLX-501, a urinary medicine; and TLX-502, a pneumonia medicine. In addition, the company provides thermometers, medical devices, and health food and products. It has a collaborative development agreement with Handa Pharmaceuticals and Handa Neuroscience, LLC for the development of TLX-050 for the treatment of neurological disorders. The company was formerly known as Actherm Inc. and changed its name to Easywell Biomedicals, Inc. in July 2015. Easywell Biomedicals, Inc. was incorporated in 1998 and is headquartered in Hsinchu City, Taiwan.
Share Price
$0.76211147
Last synced: 2026-11-10
Market Cap
$95.03M
Change (1 day)
0.40%
Change (1 year)
-32.51%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Easywell Biomedicals, Inc. (1799)
Category
Healthcare
EPS for Easywell Biomedicals, Inc. (1799)
EPS as of June 2026 TTM: $0.00
According to Easywell Biomedicals, Inc.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of $-0.02, equal to its 2024 EPS of $-0.02.
EPS history for Easywell Biomedicals, Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -80.00% |
| 2025 | $-0.02 | -23.89% |
| 2024 | $-0.02 | -40.34% |
| 2023 | $-0.04 | -8.61% |
| 2022 | $-0.05 | -12.88% |
| 2021 | $-0.05 | -20.61% |
| 2020 | $-0.07 | -44.82% |
| 2019 | $-0.12 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | -42,350.00% |
US
|
|
| $1.93 | -48,370.00% |
SE
|
|
| $6.91 | -172,950.00% |
FR
|
|
| $0.02 | -587.50% |
HK
|
|
| $2.71 | -67,845.00% |
IT
|
Questions about Easywell Biomedicals, Inc.'s earnings per share (EPS)
What is Easywell Biomedicals, Inc.'s earnings per share (EPS)?
Easywell Biomedicals, Inc.'s earnings per share (EPS) over the last twelve months is $0.00, as of Jun 2026.
What was Easywell Biomedicals, Inc.'s earnings per share (EPS) in 2025?
In 2025, Easywell Biomedicals, Inc.'s earnings per share (EPS) was $-0.02, compared with $-0.02 in 2024.
How has Easywell Biomedicals, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Easywell Biomedicals, Inc.'s earnings per share (EPS) was highest in 2025 ($-0.02) and lowest in 2020 ($-0.07).
How does Easywell Biomedicals, Inc.'s earnings per share (EPS) compare with similar companies?
Easywell Biomedicals, Inc.'s earnings per share (EPS) ($0.00) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.91.